Blood–Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study.

Autor: Kuitunen, Hanne K.¹ (AUTHOR) hanne.kuitunen@pohde.fi, Rönkä, Aino L. K.² (AUTHOR), Sonkajärvi, Eila M.³ (AUTHOR), Isokangas, Juha-Matti⁴ (AUTHOR), Pyörälä, Marja⁵ (AUTHOR), Palosaari, Kari A. A.⁴ (AUTHOR), Jokimäki, Anna S.¹ (AUTHOR), Partanen, Anu E.⁵ (AUTHOR), Littow, Harri J.⁴ (AUTHOR), Vakkala, Merja A.^3,6 (AUTHOR), Jantunen, Esa J.^5,7,8 (AUTHOR), Huttunen, Mirja E.³ (AUTHOR), Marin, Katja J.² (AUTHOR), Aromaa-Häyhä, Annikki M. K.² (AUTHOR), Auvinen, Päivi K.² (AUTHOR), Selander, Tuomas⁹ (AUTHOR), Puhakka, Inka K.¹⁰ (AUTHOR), Kuittinen, Outi M.^2,11 (AUTHOR)

Publikováno v: Cancers. Feb2023, Vol. 15 Issue 4, p1341. 12p.